Anastrozole for Men: Uses, Side Effects and TRT Guidelines

14 min readWritten by Protocol Health Editorial TeamMedically reviewed by Richard Dentico, MDPublished Updated

Anastrozole for men is an off-label use of a breast cancer drug. The FDA approved anastrozole (Arimidex) only for breast cancer in postmenopausal women; in men it is prescription-only and prescribed off-label, most often to lower estradiol during testosterone therapy or in selected fertility cases. Neither the Endocrine Society nor the American Urological Association recommends it routinely with TRT. Trials in men link suppressed estradiol to lower bone density, more body fat and reduced sexual function, and the AUA guideline points to adjusting the testosterone dose first.

Anastrozole for Men: Uses, Side Effects and TRT Guidelines
Here’s what we’ll cover

Key takeaways

What It Is

What Is Anastrozole Used For in Men?

Anastrozole for men is an off-label prescription, not an FDA-approved treatment. Anastrozole, sold as Arimidex, is an aromatase inhibitor: it blocks aromatase, the enzyme that converts testosterone into estradiol. The FDA label for Arimidex approves it for breast cancer in postmenopausal women and for no other use.

Off-label means a licensed prescriber uses an approved drug for a purpose its label does not cover. That is legal, and because the Arimidex label covers only breast cancer, it means no FDA-reviewed trial program has established how well or how safely Arimidex for men works over years.

Why do men take anastrozole? Three uses account for most prescriptions:

  • Estradiol on TRT. Some men on testosterone therapy are prescribed it when estradiol rises (Punjani et al., 2021) with breast tenderness or breast tissue growth (gynecomastia). In this role it is called an estrogen blocker for men on TRT.
  • Fertility. Reproductive urologists prescribe it off-label for selected subfertile men who have low testosterone and a low testosterone-to-estradiol ratio.
  • Low testosterone without TRT. Trials have tested it alone in older men, because blocking aromatase raises the body's own testosterone.

A 2011 review of aromatase inhibitors in men concluded that long-term efficacy and safety had not been established in males and that routine use was not recommended. Protocol Health's clinicians may prescribe anastrozole to men on TRT when it is clinically appropriate, alongside physician-supervised testosterone therapy. That is an off-label use of an FDA-approved drug. It is an individual decision based on symptoms and labs, and it is not routine for every patient. Protocol Health provides testosterone therapy and may prescribe anastrozole with it, so we have a commercial interest in both and say so here.

Why Estradiol Rises

Why Does Estradiol Rise on TRT?

Estradiol rises on TRT because the body converts part of every testosterone dose into estradiol, and in one trial estradiol rose dose-dependently with injected testosterone.

In a dose-ranging trial of 51 younger and 52 older men, estradiol rose in step with the injected testosterone dose in both age groups. Whole-body conversion ran higher in the older men, partly related to their higher body fat.

A higher estradiol number is not automatically a problem. In one large sexual medicine practice, only 3% of men on TRT were treated with anastrozole, using thresholds of estradiol above 60 pg/mL, or 40 to 60 pg/mL with symptoms. An elevated number is a reason to repeat the test and examine the patient, not a diagnosis on its own.

Free and total hormone levels are explained in what is free testosterone. High estradiol in men on TRT is a separate topic from estrogen dominance, a term used for the balance of estrogen and progesterone in women.

Guidelines

Do Men on TRT Need Anastrozole? What the Guidelines Say

The Endocrine Society and AUA guidelines say little about anastrozole with TRT, and what they say is cautious. Neither the Endocrine Society guideline nor the AUA guideline recommends routine anastrozole with TRT.

Endocrine Society (2018)

The Endocrine Society guideline on testosterone therapy contains no recommendation to add an aromatase inhibitor to testosterone therapy. Its standardized monitoring plan covers symptoms, adverse effects, adherence, serum testosterone, hematocrit and prostate cancer risk. Estradiol is not on that list.

American Urological Association (2018, validity confirmed 2024)

The American Urological Association guideline dates from 2018, and the AUA lists an amended 2024 version. The published AUA guideline includes statements for men who want to preserve fertility. The points that matter for anastrozole on TRT come from the trials below:

Anastrozole is not FDA-approved for use in males, per the Arimidex label. Taken together, the guidelines and trials treat anastrozole with TRT as an exception, not a routine add-on.

Side Effects

Anastrozole for Men: Side Effects When Estradiol Goes Too Low

The main anastrozole side effects in men come from estradiol that falls too low. Estradiol helps maintain bone, body composition and sexual function in men.

OutcomeTrialFinding
Bone density69 men aged 60 and older with low or borderline testosterone; anastrozole or placebo for one yearSpine bone density fell with anastrozole and rose with placebo (P = 0.0014)
Bone turnoverHealthy men aged 20 to 50 whose own hormone production was suppressed, then given placebo or testosterone gel with or without anastrozole for 16 weeksBone resorption rose more, and spine density fell, when conversion to estradiol was blocked
Body fat and sexual functionThe same 16-week cohort: 198 men without anastrozole, 202 with itEstrogen deficiency primarily accounted for increases in body fat and contributed to the decline in sexual function
Lipids37 men aged 62 to 74 with low testosterone; anastrozole or placebo for 12 weeksNo significant change in fasting lipids
Controlled trials of anastrozole in men and what each one measured.

Bone density

Bone is the best-documented cost. In the one-year trial led by Burnett-Bowie, anastrozole raised testosterone and lowered estradiol from 15 to 12 pg/mL, and spine bone density declined against placebo. A later analysis from the same Boston group found that estrogens primarily regulate bone in adult men, and that estradiol above 10 pg/mL with testosterone above 200 ng/dL was generally sufficient to prevent bone loss.

Body fat and libido

Body fat can rise and libido can fall when estradiol drops too low in men. The 2013 New England Journal of Medicine trial by Finkelstein and colleagues separated the effects of testosterone and estradiol in men. Androgen deficiency accounted for losses of lean mass and strength. Estrogen deficiency primarily accounted for increases in body fat, and both contributed to the decline in sexual function. Low libido and added body fat can therefore follow from low estradiol as well as from low testosterone.

Lipids

The lipid concern comes mainly from women: the Arimidex label warns that total cholesterol may increase. Small trials in men have not shown that effect: 12 weeks of anastrozole in 37 older men did not significantly change fasting lipids, and a 12-month trial in 29 older men found lipid levels similar to placebo. Trials that small cannot rule out an effect with longer use.

The Arimidex label, from studies in women, lists common adverse reactions including hot flashes, hypertension, nausea, back pain, bone pain, dyspnea and peripheral edema. The best-documented costs, though, come from estradiol pushed too low, with bone density first among them.

Benefits

Anastrozole for Men Benefits: What Trials Did and Did Not Show

The trials of anastrozole for men show narrow benefits, and they did not show long-term health gains. Anastrozole for men has two documented effects: it lowers estradiol, and in men who are not on TRT it raises testosterone. Evidence that either change improves long-term health is limited, and a review of aromatase inhibitors in men found long-term efficacy and safety unestablished.

Does anastrozole increase testosterone?

Anastrozole increases testosterone in men who make their own. In the Burnett-Bowie trial, average testosterone rose from 319 to 524 ng/dL by month three. On TRT, one uncontrolled review found no rise. In a review of 1,708 men on testosterone therapy at one sexual medicine practice, 51 men (3%) were treated with anastrozole. In those treated for elevated estradiol, the median level fell from 65 to 22 pg/mL, and testosterone was similar before and after (616 versus 596 ng/dL). The review had no control group and did not report bone outcomes.

Fertility

For fertility, the evidence on anastrozole in men is a small study without a comparison group. In a chart review of 30 subfertile men with low testosterone and a body mass index of 25 or higher, about five months of anastrozole was followed by a rise in testosterone from 270.6 to 412 ng/dL and in sperm concentration from 7.8 to 14.2 million per mL. The study had no comparison group. Other options for men planning a family include hCG, which is prescribed off-label in this setting, and enclomiphene, which is unapproved (not FDA-approved for any use). Protocol Health offers enclomiphene (see enclomiphene for men) through clinician-supervised care when appropriate and has a commercial interest in it. The guide to TRT and fertility covers them, and Clomid for men covers another option. Across these trials, the benefits are changes in hormone levels and sperm concentration, not proven long-term health gains. For realistic timelines, see TRT before and after.

Testosterone to estradiol ratio in male infertility

The testosterone to estradiol ratio in male infertility is a starting point for an individualized decision, not a fixed target. Cleveland Clinic urologists note that anastrozole has long been used off-label in infertile men with a ratio below 10. In a 2002 Weill Cornell study of 140 subfertile men with abnormal ratios, treated with anastrozole or an older aromatase inhibitor, the average ratio on anastrozole rose from 7.2 to 18.1. In the 25 men with low sperm counts who had semen tested before and during anastrozole, sperm concentration rose from 5.5 to 15.6 million per mL. The study had no placebo group.

A ratio below 10 does not decide the case on its own. In a 2022 retrospective study of 105 subfertile men, men with a ratio above 10 improved on anastrozole about as much as men below 10. In a 2023 Cleveland Clinic and UCLA cohort of 90 infertile men, neither baseline estradiol nor the estradiol-to-testosterone ratio predicted who improved. A testosterone-to-LH ratio of 100 or more and the presence of some sperm at baseline did, and 12% of the cohort saw sperm concentration fall a category. Both studies were retrospective and had no control group.

For those reasons, reproductive urologists read the testosterone to estradiol ratio alongside LH, FSH, a semen analysis and the couple's timeline. Anastrozole for male infertility is an off-label use, and the studies behind it were retrospective with no control group. The Endocrine Society guideline recommends against testosterone therapy in men planning fertility in the near term, for reasons the fertility guide above explains. Protocol Health's clinicians may prescribe anastrozole alongside TRT when clinically appropriate, and the clinic has a commercial interest in it; men whose main goal is fertility are best evaluated by a reproductive urologist. The testosterone to estradiol ratio is one input to an individualized fertility plan, not a number to chase.

Before a Blocker

What Clinicians Do Before an Estrogen Blocker for Men on TRT

Before adding an estrogen blocker for men on TRT, clinicians start with the testosterone itself. The dose steps follow from the dose-ranging trial; the others are common practice without trial support.

  • Confirm the symptom and the number. Estradiol assays vary, so clinicians repeat the test and examine the patient.
  • Watch for a period. Some clinicians wait, because breast tenderness after starting testosterone can settle without treatment.
  • Lower the testosterone dose. When on-treatment testosterone sits in the upper part of the normal range, a lower dose leaves less to convert to estradiol.
  • Change the frequency or the formulation. Some clinicians split the weekly amount into smaller, more frequent injections, or switch between injections and gel. In a review of 1,708 men on TRT at one sexual medicine practice, men treated with anastrozole were more often on injections (38.6% versus 18.5%). No trial has compared a frequency change with anastrozole.
  • Look at body fat. Higher body fat was related to higher conversion in older men in the dose-ranging trial.

The comparison of testosterone gel and injections explains how each delivers the hormone, and the testosterone cypionate guide covers injection intervals. Hematocrit, another TRT lab, is covered in how to lower hematocrit.

Dosage and Timing

Anastrozole Dosage for TRT: Why There Is No Standard Dose

There is no FDA-approved anastrozole dosage for TRT, because the Arimidex label has no approved use in men. The anastrozole for men dosage in published studies has ranged from 1 mg daily to 0.5 mg three times a week, and no trial has established which schedule is safest for bone.

How much anastrozole should I take on TRT is a question for the prescriber, who sets any dose against labs, symptoms and history. This article does not give a dose.

When to take anastrozole with testosterone

No trial has compared when to take anastrozole with testosterone, such as on injection day versus other days. Timing follows the prescriber's directions.

How long does it take for anastrozole to work on TRT?

How long anastrozole takes to work on TRT has not been measured in men, but the label gives two reference points. Anastrozole reaches steady levels in the blood after about seven days of daily dosing, and its half-life is about 50 hours, according to the FDA label, which measured this in postmenopausal women. In short, anastrozole dosage and timing on TRT are set by the prescriber, not by a standard schedule.

Questions to Ask

What Questions Should You Ask a Prescriber About Anastrozole and TRT?

The questions to ask a prescriber about anastrozole and TRT are the ones below.

  • What symptom are we treating? Breast tenderness, gynecomastia or a lab value alone?
  • How was my estradiol measured, and was the test repeated?
  • Could we adjust my testosterone dose or schedule first?
  • How will we avoid pushing estradiol too low?
  • How long would I take it? Bone density fell over one year on anastrozole.
  • Will you monitor my bone density and lipids?
  • Is this use off-label? For men, it is, per the Arimidex label.

Our Approach

TRT at Protocol Health and the Bottom Line on Anastrozole

The bottom line on anastrozole with TRT at Protocol Health is that it is an off-label option, prescribed only when clinically appropriate. Protocol Health treats low testosterone with physician-supervised testosterone replacement therapy (our TRT for men guide explains it), in person in Scarsdale, NY, and by telehealth in New York, New Jersey, Connecticut, Florida and California. Care starts with a consultation and baseline labs. Protocol Health's TRT monitoring pairs follow-up labs with a review of symptoms, and the treating clinician decides whether a dose or schedule should change. Raise estradiol or breast symptoms at that visit instead of adding a medication on your own.

Protocol Health's clinicians may prescribe anastrozole to men on TRT when it is clinically appropriate. Anastrozole for men is an off-label use of an FDA-approved drug. The decision is individual, based on symptoms and labs, and anastrozole is not routine for every patient on TRT.

Anastrozole for men is an off-label, prescription-only drug with a narrow role. It lowers estradiol, the Endocrine Society guideline does not recommend it routinely with TRT, and trials in men show bone, body-fat and sexual-function costs when estradiol falls too far. The sensible sequence starts with the symptom and the testosterone dose, before a second drug. Normal ranges are in the testosterone levels by age chart. Start with the two-minute health quiz.

Bottom Line

The Bottom Line

Anastrozole for men is an off-label drug with a narrow role on TRT, not a routine add-on.

FAQ

Frequently Asked Questions

What does anastrozole do to a man?

Anastrozole blocks aromatase, the enzyme that converts testosterone into estradiol, so estradiol falls. In men who are not on TRT, testosterone rises as a result: in one trial it went from 319 to 524 ng/dL by month three (Burnett-Bowie et al., 2009). Estradiol supports bone, body composition and sexual function in men, so lowering it too far carries risks.

Is anastrozole FDA-approved for men?

No. Anastrozole (Arimidex) is FDA-approved only for breast cancer in postmenopausal women, according to the FDA label. Use in men is off-label and requires a prescription.

Is Arimidex the same as anastrozole for men?

Yes. Arimidex is the brand name of anastrozole, and the FDA label lists breast cancer in postmenopausal women as its only approved use. Whether a man is prescribed brand Arimidex or generic anastrozole, the use is off-label. Doctors do prescribe it to men, though not routinely: in one practice's review of 1,708 men on TRT, 3% were treated with anastrozole.

Do men on TRT need an estrogen blocker?

No, not routinely. Neither the Endocrine Society nor the AUA guideline recommends one routinely. In one practice’s review of 1,708 men on TRT, 3% were treated with anastrozole. Because estradiol rises with the testosterone dose, clinicians often adjust the dose first.

What are the side effects of anastrozole in men?

The best-documented effect is lower bone density: in a one-year placebo-controlled trial of 69 older men, spine bone density fell with anastrozole. In a 16-week trial, estrogen deficiency was tied to more body fat and reduced sexual function. The Arimidex label, from studies in women, also lists hot flashes, hypertension, nausea and bone pain.

Does anastrozole cause fat loss in men?

No, fat loss is not an established effect of anastrozole in men. In a 16-week trial of healthy men, estrogen deficiency primarily accounted for increases in body fat. One 12-month trial recorded less abdominal subcutaneous fat in 10 older men on anastrozole; its authors called for larger trials.

Does Protocol Health prescribe anastrozole with TRT?

Yes, when it is clinically appropriate. Protocol Health's clinicians may prescribe anastrozole to men on TRT as an off-label use of an FDA-approved drug. It is an individual decision based on symptoms and labs, and it is not routine for every patient.

Can I get TRT through telehealth?

Yes, in licensed states. Protocol Health sees patients in person in Scarsdale, NY, and by telehealth in New York, New Jersey, Connecticut, Florida and California. Care starts with a consultation and baseline labs, and whether testosterone therapy is appropriate is decided case by case.

Explore

Related at Protocol Health

Book a TRT consultation

Medical disclaimer

This article is for education only and is not medical advice, diagnosis, or treatment. Talk to a licensed clinician before starting, stopping, or changing any medication.

Important safety information

References

  1. U.S. Food and Drug Administration. ARIMIDEX (anastrozole) prescribing information. DailyMed. https://dailymed.nlm.nih.gov/dailymed/drugInfo.cfm?setid=acbfaaa9-503c-4691-9828-76a7146ed6de
  2. Lakshman KM et al., 2010. The effects of injected testosterone dose and age on the conversion of testosterone to estradiol and dihydrotestosterone in young and older men. J Clin Endocrinol Metab. PMID 20534765. https://pubmed.ncbi.nlm.nih.gov/20534765/
  3. Bhasin S et al., 2018. Testosterone Therapy in Men With Hypogonadism: An Endocrine Society Clinical Practice Guideline. J Clin Endocrinol Metab. PMID 29562364. https://pubmed.ncbi.nlm.nih.gov/29562364/
  4. Burnett-Bowie SA et al., 2009. Effects of aromatase inhibition on bone mineral density and bone turnover in older men with low testosterone levels. J Clin Endocrinol Metab. PMID 19820017. https://pubmed.ncbi.nlm.nih.gov/19820017/
  5. Punjani N et al., 2021. The Utilization and Impact of Aromatase Inhibitor Therapy in Men With Elevated Estradiol Levels on Testosterone Therapy. Sex Med. PMID 34090245. https://pubmed.ncbi.nlm.nih.gov/34090245/
  6. Cleveland Clinic Consult QD. Study Suggests Broader Use of Anastrozole for Male Infertility. https://consultqd.clevelandclinic.org/study-suggests-broader-use-of-anastrozole-for-male-infertility
  7. de Ronde W, de Jong FH, 2011. Aromatase inhibitors in men: effects and therapeutic options. Reprod Biol Endocrinol. PMID 21693046. https://pubmed.ncbi.nlm.nih.gov/21693046/
  8. Mulhall JP et al., 2018. Evaluation and Management of Testosterone Deficiency: AUA Guideline. J Urol. PMID 29601923. https://pubmed.ncbi.nlm.nih.gov/29601923/
  9. American Urological Association, 2018 (amended 2024). Evaluation and Management of Testosterone Deficiency guideline. https://www.auanet.org/guidelines-and-quality/guidelines/testosterone-deficiency-guideline
  10. Flores JM et al., 2023. Clomiphene citrate therapy for testosterone deficiency: a proposed clinical care pathway. J Sex Med. PMID 37122109. https://pmc.ncbi.nlm.nih.gov/articles/PMC10149379/
Show all 18 references
  1. Finkelstein JS et al., 2016. Gonadal steroid-dependent effects on bone turnover and bone mineral density in men. J Clin Invest. PMID 26901812. https://pubmed.ncbi.nlm.nih.gov/26901812/
  2. Finkelstein JS et al., 2013. Gonadal steroids and body composition, strength, and sexual function in men. N Engl J Med. PMID 24024838. https://pubmed.ncbi.nlm.nih.gov/24024838/
  3. Dougherty RH et al., 2005. Effect of aromatase inhibition on lipids and inflammatory markers of cardiovascular disease in elderly men with low testosterone levels. Clin Endocrinol (Oxf). PMID 15670201. https://pubmed.ncbi.nlm.nih.gov/15670201/
  4. Dias JP et al., 2017. Testosterone vs. aromatase inhibitor in older men with low testosterone: effects on cardiometabolic parameters. Andrology. PMID 27792869. https://pubmed.ncbi.nlm.nih.gov/27792869/
  5. Shah T et al., 2021. Efficacy of anastrozole in the treatment of hypogonadal, subfertile men with body mass index of 25 or higher. Transl Androl Urol. PMID 33850757. https://pubmed.ncbi.nlm.nih.gov/33850757/
  6. Raman JD, Schlegel PN, 2002. Aromatase inhibitors for male infertility. J Urol. PMID 11792932. https://pubmed.ncbi.nlm.nih.gov/11792932/
  7. Yang Y et al., 2022. The efficacy of anastrozole in subfertile men with and without abnormal testosterone to estradiol ratios. Transl Androl Urol. PMID 36217397. https://pubmed.ncbi.nlm.nih.gov/36217397/
  8. Naelitz BD et al., 2023. Testosterone and luteinizing hormone predict semen parameter improvement in infertile men treated with anastrozole. Fertil Steril. PMID 37392782. https://pubmed.ncbi.nlm.nih.gov/37392782/

Why trust our physicians

Every article is reviewed by a licensed physician on our medical team and is kept current by our editorial team. Read our editorial policy and our medical review process.

Medically reviewed by
Richard Dentico, MD on
Written by
Protocol Health Editorial Team
First published
Last updated

See an error? Email care@protocolhealthmd.com and we will review it.

More on Testosterone & TRT

All Hormone Health articles →